Dosing underway in Pfizer’s late-stage talazoparib/enzalutamide combo study in prostate cancer
June 23 2021 - 6:57AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Pfizer (NYSE:PFE)
Historical Stock Chart
From Aug 2024 to Sep 2024
Pfizer (NYSE:PFE)
Historical Stock Chart
From Sep 2023 to Sep 2024